These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 26218637
1. Salvage of nicotinamide adenine dinucleotide plays a critical role in the bioenergetic recovery of post-hypoxic cardiomyocytes. Gero D, Szabo C. Br J Pharmacol; 2015 Oct; 172(20):4817-32. PubMed ID: 26218637 [Abstract] [Full Text] [Related]
2. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders. Henning RJ, Bourgeois M, Harbison RD. Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072 [Abstract] [Full Text] [Related]
3. Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes. Gerö D, Szoleczky P, Chatzianastasiou A, Papapetropoulos A, Szabo C. Mol Med; 2014 Jul 31; 20(1):313-28. PubMed ID: 24842055 [Abstract] [Full Text] [Related]
5. Nicotinamide pretreatment protects cardiomyocytes against hypoxia-induced cell death by improving mitochondrial stress. Tong DL, Zhang DX, Xiang F, Teng M, Jiang XP, Hou JM, Zhang Q, Huang YS. Pharmacology; 2012 Mar 31; 90(1-2):11-8. PubMed ID: 22699421 [Abstract] [Full Text] [Related]
6. Astrocytic poly(ADP-ribose) polymerase-1 activation leads to bioenergetic depletion and inhibition of glutamate uptake capacity. Tang KS, Suh SW, Alano CC, Shao Z, Hunt WT, Swanson RA, Anderson CM. Glia; 2010 Mar 31; 58(4):446-57. PubMed ID: 19795500 [Abstract] [Full Text] [Related]
7. Reduced nicotinamide adenine dinucleotide fluorescence lifetime detected poly(adenosine-5'-diphosphate-ribose) polymerase-1-mediated cell death and therapeutic effect of pyruvate. Guo HW, Wei YH, Wang HW. J Biomed Opt; 2011 Jun 31; 16(6):068001. PubMed ID: 21721834 [Abstract] [Full Text] [Related]
8. NAD+ as a metabolic link between DNA damage and cell death. Ying W, Alano CC, Garnier P, Swanson RA. J Neurosci Res; 2011 Jun 31; 79(1-2):216-23. PubMed ID: 15562437 [Abstract] [Full Text] [Related]
9. Nicotinamide pre-treatment ameliorates NAD(H) hyperoxidation and improves neuronal function after severe hypoxia. Shetty PK, Galeffi F, Turner DA. Neurobiol Dis; 2014 Feb 31; 62():469-78. PubMed ID: 24184921 [Abstract] [Full Text] [Related]
10. NAD+ overconsumption by poly (ADP-ribose) polymerase (PARP) under oxidative stress induces cytoskeletal disruption in vascular endothelial cell. Nakajo T, Katayoshi T, Kitajima N, Tsuji K. Biochem Biophys Res Commun; 2024 Oct 30; 731():150371. PubMed ID: 39004065 [Abstract] [Full Text] [Related]
11. NAD+-A Hub of Energy Metabolism in Heart Failure. Wu Y, Pei Z, Qu P. Int J Med Sci; 2024 Oct 30; 21(2):369-375. PubMed ID: 38169534 [Abstract] [Full Text] [Related]
12. Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson's disease. Lehmann S, Costa AC, Celardo I, Loh SH, Martins LM. Cell Death Dis; 2016 Mar 31; 7(3):e2166. PubMed ID: 27031963 [Abstract] [Full Text] [Related]
13. Nicotinamide pretreatment alleviates mitochondrial stress and protects hypoxic myocardial cells via AMPK pathway. Lai YF, Wang L, Liu WY. Eur Rev Med Pharmacol Sci; 2019 Feb 31; 23(4):1797-1806. PubMed ID: 30840306 [Abstract] [Full Text] [Related]
14. Thrombin or Ca(++)-ionophore-mediated fall in endothelial ATP levels independent of poly(ADP-Ribose) polymerase activity and NAD levels--comparison with the effects of hydrogen peroxide. Halldórsson H, Thors B, Thorgeirsson G. Nucleosides Nucleotides Nucleic Acids; 2015 Feb 31; 34(4):246-57. PubMed ID: 25774718 [Abstract] [Full Text] [Related]
15. Differential effects of hyperoxia and hydrogen peroxide on DNA damage, polyadenosine diphosphate-ribose polymerase activity, and nicotinamide adenine dinucleotide and adenosine triphosphate contents in cultured endothelial cells and fibroblasts. Junod AF, Jornot L, Petersen H. J Cell Physiol; 1989 Jul 31; 140(1):177-85. PubMed ID: 2500451 [Abstract] [Full Text] [Related]
16. Reactive oxygen injury to cultured pulmonary artery endothelial cells: mediation by poly(ADP-ribose) polymerase activation causing NAD depletion and altered energy balance. Thies RL, Autor AP. Arch Biochem Biophys; 1991 May 01; 286(2):353-63. PubMed ID: 1654786 [Abstract] [Full Text] [Related]
17. Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function. Klaidman L, Morales M, Kem S, Yang J, Chang ML, Adams JD. Pharmacology; 2003 Nov 01; 69(3):150-7. PubMed ID: 14512702 [Abstract] [Full Text] [Related]
18. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide. Cosi C, Marien M. Brain Res; 1998 Oct 26; 809(1):58-67. PubMed ID: 9795136 [Abstract] [Full Text] [Related]
19. Atrial bioenergetic variations in moderate hypoxia: danger or protective defense? Caparrotta L, Poja R, Ragazzi E, Froldi G, Pandolfo L, Prosdocimi M, Fassina G. Basic Res Cardiol; 1989 Oct 26; 84(5):449-60. PubMed ID: 2818445 [Abstract] [Full Text] [Related]
20. Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions. Martire S, Fuso A, Mosca L, Forte E, Correani V, Fontana M, Scarpa S, Maras B, d'Erme M. J Alzheimers Dis; 2016 Aug 10; 54(1):307-24. PubMed ID: 27567805 [Abstract] [Full Text] [Related] Page: [Next] [New Search]